Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-costliest quintile among peers.
Hartford International Opp HLS IB HBIOX
- NAV / 1-Day Return 16.77 / +1.08 %
- Total Assets 858.6 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.010%
- Distribution Fee Level High
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Growth
- Min. Initial Investment —
- Status Open
- TTM Yield 0.78%
- Turnover 54%
USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 10:12 PM GMT+0
Morningstar’s Analysis HBIOX
Will HBIOX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 25.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Taiwan Semiconductor Manufacturing Co Ltd | 4.24 | 37.0 Mil | Technology |
Samsung Electronics Co Ltd | 2.66 | 23.2 Mil | Technology |
Tencent Holdings Ltd | 2.54 | 22.2 Mil | Communication Services |
AstraZeneca PLC | 2.53 | 22.1 Mil | Healthcare |
ASML Holding NV | 2.48 | 21.6 Mil | Technology |
Novo Nordisk A/S Class B | 2.36 | 20.6 Mil | Healthcare |
Shell PLC | 2.32 | 20.2 Mil | Energy |
Novartis AG Registered Shares | 2.12 | 18.5 Mil | Healthcare |
Mitsubishi UFJ Financial Group Inc | 2.06 | 18.0 Mil | Financial Services |
Unilever PLC | 1.95 | 17.0 Mil | Consumer Defensive |